Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN) have been assigned an average rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and two have given a strong buy recommendation to the company.

STVN has been the subject of several recent research reports. Weiss Ratings upgraded shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. UBS Group initiated coverage on Stevanato Group in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $23.00 target price on the stock. Finally, TD Cowen raised Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th.

Insiders Place Their Bets

In other Stevanato Group news, Director Elisabetta Magistretti sold 2,045 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €41,084.05. Following the completion of the transaction, the director owned 2,930 shares in the company, valued at approximately €58,863.70. This represents a 41.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Mauro Stocchi sold 13,649 shares of the firm’s stock in a transaction on Monday, September 28th. The shares were sold at an average price of €21.50, for a total value of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares of the company’s stock, valued at approximately €8,600,000. This trade represents a 3.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 21,926 shares of company stock worth $459,738.

Institutional Trading of Stevanato Group

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Conestoga Capital Advisors LLC increased its holdings in Stevanato Group by 7.6% in the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after buying an additional 602,050 shares in the last quarter. Wellington Management Group LLP purchased a new stake in Stevanato Group during the second quarter worth $22,621,000. Ranger Investment Management L.P. acquired a new stake in Stevanato Group in the second quarter valued at $21,438,000. Cooper Investors PTY Ltd. raised its stake in shares of Stevanato Group by 4.4% during the 2nd quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company’s stock worth $12,080,000 after buying an additional 28,265 shares during the last quarter. Finally, Sands Capital Management LLC increased its holdings in Stevanato Group by 6.0% during the 4th quarter. Sands Capital Management LLC now owns 493,006 shares of the company’s stock valued at $9,919,000 after acquiring an additional 28,075 shares in the last quarter.

Stevanato Group Stock Performance

Shares of STVN opened at €20.05 on Thursday. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The firm has a market cap of $6.07 billion, a PE ratio of 35.81, a price-to-earnings-growth ratio of 1.65 and a beta of 0.78. The company’s 50 day simple moving average is €21.11 and its 200-day simple moving average is €18.52. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €27.99.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The business had revenue of €302.00 million during the quarter. As a group, equities analysts predict that Stevanato Group will post 0.69 EPS for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.